Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,958 total articles
Allogene Therapeutics, a clinical-stage biotech company focusing on allogeneic CAR T cell therapies, has priced a public offering of 87.5 million shares at $2.00 per share, expected to raise $175 million before expenses. The offering will fund general corporate purposes including clinical trials, research and development, and administrative expense…
SAB Biotherapeutics, listed on Nasdaq as SABS, announced upcoming oral and poster presentations highlighting new clinical and mechanistic data on SAB-142, their lead immunotherapy candidate for newly diagnosed Stage 3 type 1 diabetes (T1D). The data showcase SAB-142's multi-specific binding profile and potential as a best-in-class disease-modifying…
Rezolve Ai has appointed James House as CEO of Reward, its recently acquired banking and commerce media business. House's extensive experience at Mastercard and BNP Paribas positions him to scale Reward's international footprint and expand its offerings within the AI-driven commerce ecosystem. The move supports Rezolve Ai's strategy to unify bankin…
Dime announced several significant executive and managerial hires from prominent banks such as Flagstar and Metropolitan Commercial Bank, adding approximately 22 bankers in total. These hires include leadership roles aimed at driving growth in multiple New York and New Jersey markets, along with the establishment of a new Equipment and Franchise Fi…
Spyre Therapeutics announced the pricing of an upsized underwritten public offering of 6.5 million shares of common stock at $62 per share, expected to raise approximately $403 million before expenses. The offering, which may include an additional 30-day option for 975,000 shares, is intended to fund the advancement of Spyre's clinical-stage pipeli…
Allogene Therapeutics announced the publication of preclinical data in Nature Communications for ALLO-329, an investigational allogeneic dual-targeted CD19/CD70 CAR T therapy aimed at treating autoimmune diseases such as lupus, myositis, and scleroderma. The data demonstrate enhanced CAR T cell expansion, persistence, and efficacy through the Dagge…
H2O America, a water and wastewater utility company listed on NASDAQ as HTO, will report its first quarter 2026 financial results on April 28, 2026, after market close. The company will host a conference call on April 29 with key executives to discuss results and recent developments, accessible via webcast.
Plexus Corp. has scheduled the release of its fiscal second quarter 2026 earnings on April 29, 2026, with a follow-up management conference call on April 30, 2026. The company provides advanced design, manufacturing, and service solutions across Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors.
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, announced its participation in four upcoming investor conferences during the second quarter of 2026, aiming to present its pipeline progress and strategic outlook to investors and stakeholders.
Inuvo, Inc. has announced a strategic integration of its AI-driven IntentKey technology into FreeWheel's Buyer Cloud demand-side platform, enhancing programmatic media buying capabilities. This partnership enables real-time bidding decisions based on consumer intent analyzed through proprietary AI models, providing advertisers with greater control,…
Mount Logan Capital Inc. will participate in the B. Riley Securities 2026 Annual Investor Conference held on May 20-21, 2026, in Marina del Rey. The company's executive team will hold investor meetings to discuss their integrated alternative asset management and insurance solutions business, emphasizing their approach to generating durable, fee-bas…
Costco Wholesale Corporation declared a quarterly cash dividend increase from $1.30 to $1.47 per share, payable on May 15, 2026. This raises the annualized dividend to $5.88, signaling confidence in the company's continued profitability and cash flow. The company operates over 900 warehouses globally and maintains a broad e-commerce presence.
Runway Growth Finance Corp., a Nasdaq-listed specialty finance company providing flexible capital solutions to late- and growth-stage companies, will release its first quarter 2026 financial results after market close on May 7, 2026, followed by a conference call to discuss the results. The company is externally managed by an affiliate of BC Partne…
Royalty Pharma plc announced it will release its first quarter 2026 financial results on May 6, 2026, accompanied by a conference call and webcast. The company, a leading acquirer and funder of biopharmaceutical royalties, continues to manage a diverse portfolio including royalties from major pharmaceutical products and development-stage candidates…
Revolution Medicines, a clinical-stage oncology firm focusing on RAS-addicted cancer therapies, announced an increase in its concurrent public offerings to raise approximately $2 billion. The offerings include about 10.56 million shares of common stock priced at $142 per share (up from $750 million to $1.5 billion) and $500 million in 0.5% converti…
The Progressive Corporation reported solid financial results for March 2026 and the first quarter, showing growth in net premiums written by 10% for the month and 6% for the quarter. Net income increased by 36% in March and 10% for the quarter compared to the previous year. The combined ratio improved slightly for the month but was flat for the qua…
Genco Shipping & Trading Limited, a US-based drybulk ship owning company, announced its first quarter 2026 earnings release date and the associated conference call details. The company will report its financial results on May 6, 2026, followed by a live webcast and conference call on May 7, 2026, to discuss the results and provide investor updates.
InterDigital, Inc. unveiled findings from a report highlighting its AI-enabled Pixel Value Reduction (PVR) technology, which extends smartphone video viewing time by up to 22% and reduces energy consumption on TVs and other devices by up to 15%. PVR optimizes display luminance and contrast to save power without compromising image quality. The techn…
Amarin Corporation plc will report its first quarter 2026 financial results on April 29, 2026, followed by a live webcast conference call with senior management. The company highlights its commitment to cardiovascular disease therapeutics and provides information on accessing the call and replay. Investors are encouraged to review posted materials …
NEXGEL, Inc. has rescheduled its shareholder update conference call to April 23, 2026 to provide updates on its potential transaction with Celularity Inc. The company announced it will not finance the transaction under its previous agreement and is negotiating a new financing structure with another investor group. Details on the transaction and fin…
T3 Defense Inc. announced its unaudited preliminary financial and operational results for Q1 2026, the company's first full quarter operating as a defense-focused holding company. The company expects Q1 revenue of approximately $4.2 million and confirms its full-year 2026 revenue guidance of $26 million, supported by a robust backlog of over $12 mi…
Achieve Life Sciences announced the successful transfer of cytisinicline manufacturing technology to US-based Adare Pharma Solutions, including completion of analytical method transfer and production of the first engineering batch. Despite previous FDA cGMP inspection concerns at the former facility, Achieve plans to resubmit its NDA with Adare as …
Brilliant Earth Group, a leading ethically sourced fine jewelry company, will report its first quarter 2026 earnings after market close on May 6, 2026, accompanied by an investor webcast and conference call. The company emphasizes its continued mission to transform the jewelry industry with sustainable practices and reports strong 2025 net sales pe…
Reviva Pharmaceuticals provided an update to shareholders detailing its recent $10 million financing to strengthen cash reserves, plans to extend the patent life of its lead drug candidate brilaroxazine through a new formulation, and preparations to initiate a second Phase 3 schizophrenia trial (RECOVER-2). The company seeks FDA alignment on the ne…
Adamas Trust, Inc., a REIT focusing on capital deployment across real estate and capital markets, will report its Q1 2026 financial results after market close on April 29, 2026, followed by a conference call on April 30, 2026.
